These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 646240)

  • 21. Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets.
    Anderson RA; Polansky MM; Bryden NA; Canary JJ
    Am J Clin Nutr; 1991 Nov; 54(5):909-16. PubMed ID: 1951165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin, glucagon and growth hormone in primary adult myxoedema.
    Andreani D; Fallucca F; Tamburrano G; Iavicoli M; Menzinger G
    Diabetologia; 1974 Feb; 10(1):7-12. PubMed ID: 4835609
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induced hyperglycemia and its relationship to underweight fetuses: study on a newborn infant].
    Berland H; Moessner F; Willard D; Freyss E; Tissier J
    J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):235-43. PubMed ID: 1230487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
    Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH
    JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The acute effect of the human growth hormone under hyperglycemic conditions in man (author's transl)].
    Takeda S
    Nihon Naibunpi Gakkai Zasshi; 1978 Aug; 54(8):994-1006. PubMed ID: 720705
    [No Abstract]   [Full Text] [Related]  

  • 29. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
    Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
    Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA in maturity-onset type of hyperglycemia in the young.
    Barbosa J; King R; Goetz FC; Noreen H; Yunis EJ
    Arch Intern Med; 1978 Jan; 138(1):90-3. PubMed ID: 619834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensitivity to insulin in patients with diabetes mellitus].
    Levchenko TP
    Probl Endokrinol (Mosk); 1984; 30(5):13-6. PubMed ID: 6095255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration.
    DeFronzo RA; Hendler R; Christensen N
    Diabetes; 1980 Feb; 29(2):125-31. PubMed ID: 6986297
    [No Abstract]   [Full Text] [Related]  

  • 36. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galanin-induced hyperglycemia: effect on insulin and glucagon.
    Manabe T; Yoshimura T; Kii E; Tanaka Y; Ohshio G; Tobe T; Akaji K; Yajima H
    Endocr Res; 1986; 12(1):93-8. PubMed ID: 2422025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Weinger K; Jacobson AM; Draelos MT; Finkelstein DM; Simonson DC
    Am J Med; 1995 Jan; 98(1):22-31. PubMed ID: 7825615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
    Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.